ClearSight Therapeutics is a biotech firm focusing on creating pharmaceutical and medical device solutions for ophthalmology.
ClearSight Therapeutics has raised $307K in total funding. The most recent round was Grant. The last funding was announced in September 2026.
ClearSight Therapeutics's investors include National Eye Institute, Health Wildcatters.
ClearSight Therapeutics is headquartered in Dallas, United States.
ClearSight Therapeutics is a biotech firm focusing on creating pharmaceutical and medical device solutions for ophthalmology.
ClearSight Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ClearSight Therapeutics — Funding & Investors." VCBacked, September 22, 2026, https://www.vcbacked.co/company/clearsight-therapeutics. Accessed October 1, 2026.
VCBacked. (2026). ClearSight Therapeutics — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/clearsight-therapeutics
{{cite web |title=ClearSight Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/clearsight-therapeutics |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated